Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bunker

Showing results (1141-1150 of 1,207) with videos related to

Pageof 121
Sort By:
Nature|June 5, 2020
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin KMikołaj Słabicki, Zuzanna Kozicka, Georg Petzold, et al.
Nature|December 18, 2024
A dormant overmassive black hole in the early UniverseIgnas Juodžbalis, Roberto Maiolino, William M Baker, et al.
Journal of Affective Disorders|December 26, 2024
Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial reportVictoria C de Leon, Rebecca M Allen, João Quevedo, et al.
The Journal of Clinical Psychiatry|July 14, 2026
Impact of Vagus Nerve Stimulation on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study ReportVasilis C Hristidis, Victoria De Leon, Andrew D Van Der Vaart, et al.
Carcinogenesis|June 28, 2011
Multi-institutional prostate cancer study of genetic susceptibility in populations of African descentEmanuela Taioli, Rafael E Flores-Obando, Ilir Agalliu, et al.
Infectious Agents and Cancer|September 26, 2007
African-Caribbean cancer consortium for the study of viral, genetic and environmental cancer risk factorsCamille C Ragin, Emanuela Taioli, Norma McFarlane-Anderson, et al.
Brain Stimulation|April 4, 2024
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial reportCharles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
Science (New York, N.Y.)|April 10, 1981
Encounter with saturn: voyager 1 imaging science resultsB A Smith, L Soderblom, R Beebe, et al.
NPJ Precision Oncology|January 4, 2025
Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancersDaehwan Kim, Heekyung Chung, Wen Liu, et al.
Science (New York, N.Y.)|January 29, 1982
A new look at the saturn system: the voyager 2 imagesB A Smith, L Soderblom, R Batson, et al.
Pageof 121

Showing results (1141-1150 of 1,207) with videos related to

Sort By:
Pageof 121
Nature|June 5, 2020
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin KMikołaj Słabicki, Zuzanna Kozicka, Georg Petzold, et al.
Nature|December 18, 2024
A dormant overmassive black hole in the early UniverseIgnas Juodžbalis, Roberto Maiolino, William M Baker, et al.
Journal of Affective Disorders|December 26, 2024
Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial reportVictoria C de Leon, Rebecca M Allen, João Quevedo, et al.
The Journal of Clinical Psychiatry|July 14, 2026
Impact of Vagus Nerve Stimulation on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study ReportVasilis C Hristidis, Victoria De Leon, Andrew D Van Der Vaart, et al.
Carcinogenesis|June 28, 2011
Multi-institutional prostate cancer study of genetic susceptibility in populations of African descentEmanuela Taioli, Rafael E Flores-Obando, Ilir Agalliu, et al.
Infectious Agents and Cancer|September 26, 2007
African-Caribbean cancer consortium for the study of viral, genetic and environmental cancer risk factorsCamille C Ragin, Emanuela Taioli, Norma McFarlane-Anderson, et al.
Brain Stimulation|April 4, 2024
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial reportCharles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
Science (New York, N.Y.)|April 10, 1981
Encounter with saturn: voyager 1 imaging science resultsB A Smith, L Soderblom, R Beebe, et al.
NPJ Precision Oncology|January 4, 2025
Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancersDaehwan Kim, Heekyung Chung, Wen Liu, et al.
Science (New York, N.Y.)|January 29, 1982
A new look at the saturn system: the voyager 2 imagesB A Smith, L Soderblom, R Batson, et al.
Pageof 121